stable trimeric influenza hemagglutinin stem broadly protective immunogen 
identification human broadly neutralizing antibodies bnabs targeting hemagglutinin ha stem revitalized hopes developing universal influenza vaccine using rational design library approach engineered stable ha stem antigens "mini-has" based h1 subtype sequence advanced candidate exhibits structural bnab binding properties comparable full-length ha completely protects mice lethal heterologous heterosubtypic challenge models reduces fever sublethal challenge cynomolgus monkeys antibodies elicited mini-ha mice nonhuman primates bound wide range competed human bnabs ha stem binding neutralized h5n1 viruses mediated antibody-dependent effector activity results represent proof concept design ha stem mimics elicit bnabs influenza group viruses 
